Arcus Biosciences, Inc. (RCUS) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 17M | 33M | 26M | 160M | 28M | 26M | 48M | 39M | 145M | 31M | 32M | 29M |
| Revenue Growth % | -39.29% | 26.92% | -45.83% | 310.26% | -80.69% | -16.13% | 50% | 34.48% | 480% | -7.89% | -3.03% | 7.41% |
| Cost of Goods Sold | 0 | 3M | 2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | 9.09% | 7.69% | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 30M | 24M | 160M | 28M | 26M | 48M | 39M | 145M | 31M | 32M | 29M |
| Gross Margin % | - | 90.91% | 92.31% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | -100% | 15.38% | -50% | 310.26% | -80.69% | -16.13% | 50% | 34.48% | 480% | -7.89% | -3.03% | 7.41% |
| Operating Expenses | 151M | 144M | 166M | 168M | 150M | 129M | 153M | 145M | 161M | 122M | 112M | 112M |
| OpEx % of Revenue | 888.24% | 436.36% | 638.46% | 105% | 535.71% | 496.15% | 318.75% | 371.79% | 111.03% | 393.55% | 350% | 386.21% |
| Selling, General & Admin | 29M | 26M | 27M | 29M | 28M | 28M | 30M | 30M | 32M | 29M | 30M | 28M |
| SG&A % of Revenue | 170.59% | 78.79% | 103.85% | 18.13% | 100% | 107.69% | 62.5% | 76.92% | 22.07% | 93.55% | 93.75% | 96.55% |
| Research & Development | 122M | 121M | 141M | 139M | 122M | 101M | 123M | 115M | 109M | 93M | 82M | 84M |
| R&D % of Revenue | 717.65% | 366.67% | 542.31% | 86.88% | 435.71% | 388.46% | 256.25% | 294.87% | 75.17% | 300% | 256.25% | 289.66% |
| Other Operating Expenses | 0 | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | 0 |
| Operating Income | -134M | -114M | -142M | -8M | -122M | -103M | -105M | -106M | -16M | -91M | -80M | -83M |
| Operating Margin % | -788.24% | -345.45% | -546.15% | -5% | -435.71% | -396.15% | -218.75% | -271.79% | -11.03% | -293.55% | -250% | -286.21% |
| Operating Income Growth % | -9.84% | -10.68% | -35.24% | 92.45% | -662.5% | -13.19% | -31.25% | -27.71% | 81.4% | -22.24% | -14.29% | -20.29% |
| EBITDA | -134M | -111M | -140M | -6M | -119M | -100M | -103M | -104M | -13M | -88M | -79M | -81M |
| EBITDA Margin % | -788.24% | -336.36% | -538.46% | -3.75% | -425% | -384.62% | -214.58% | -266.67% | -8.97% | -283.87% | -246.88% | -279.31% |
| EBITDA Growth % | -12.61% | -11% | -35.92% | 94.23% | -815.38% | -13.64% | -30.38% | -28.4% | 84.52% | -20.61% | -16.18% | -20.9% |
| D&A (Non-Cash Add-back) | 0 | 3M | 2M | 2M | 3M | 3M | 2M | 2M | 3M | 3M | 1M | 2M |
| EBIT | 0 | -84M | -132M | 2M | -111M | -92M | -91M | -93M | -3M | -80M | -68M | -74M |
| Net Interest Income | 0 | 17M | 7M | 8M | 10M | 10M | 13M | 13M | 12M | 11M | 11M | 9M |
| Interest Income | 0 | 31M | 10M | 10M | 11M | 12M | 14M | 13M | 13M | 11M | 12M | 9M |
| Interest Expense | -3M | 14M | 3M | 2M | 1M | 2M | 1M | 0 | 1M | 0 | 1M | 0 |
| Other Income/Expense | 6M | 16M | 7M | 0 | 10M | 9M | 13M | 13M | 12M | 11M | 11M | 9M |
| Pretax Income | -128M | -98M | -135M | -8M | -112M | -94M | -92M | -93M | -4M | -80M | -69M | -74M |
| Pretax Margin % | -752.94% | -296.97% | -519.23% | -5% | -400% | -361.54% | -191.67% | -238.46% | -2.76% | -258.06% | -215.63% | -255.17% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 1M | 0 | 0 | 0 | 1M | 2M | 1M |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | -1.06% | 0% | 0% | 0% | -1.25% | -2.9% | -1.35% |
| Net Income | -128M | -98M | -135M | -8M | -112M | -94M | -92M | -93M | -4M | -81M | -71M | -75M |
| Net Margin % | -752.94% | -296.97% | -519.23% | -5% | -400% | -361.54% | -191.67% | -238.46% | -2.76% | -261.29% | -221.88% | -258.62% |
| Net Income Growth % | -14.29% | -4.26% | -46.74% | 91.4% | -2700% | -16.05% | -29.58% | -24% | 95% | -20.08% | -9.23% | -11.94% |
| Net Income (Continuing) | -128M | -98M | -135M | -8M | -112M | -95M | -92M | -93M | -4M | -81M | -71M | -75M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.02 | -0.92 | -1.27 | 0.04 | -1.14 | -1.03 | -1.01 | -1.02 | -0.05 | -1.08 | -0.95 | -1.02 |
| EPS Growth % | 10.53% | 10.68% | -25.74% | 104.25% | -2356.9% | 4.63% | -6.32% | 0% | 95.78% | -17.39% | -13.1% | -13.33% |
| EPS (Basic) | -1.02 | -0.92 | -1.27 | 0.04 | -1.14 | -1.03 | -1.01 | -1.02 | -0.05 | -1.08 | -0.95 | -1.02 |
| Diluted Shares Outstanding | 125.4M | 107.4M | 106.5M | 106.5M | 98.4M | 91.7M | 91.4M | 91.1M | 86.2M | 75M | 74.6M | 73.2M |
| Basic Shares Outstanding | 125.4M | 107.4M | 106.5M | 106.1M | 98.4M | 91.7M | 91.4M | 91.1M | 86.2M | 75M | 74.6M | 73.2M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |